NCT00003394View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions
Prostate Cancer
Interventions
DRUG

carboplatin

DRUG

endocrine-modulating drug therapy

DRUG

estramustine phosphate sodium

DRUG

goserelin acetate

DRUG

leuprolide acetate

DRUG

paclitaxel

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003394 - Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer | Biotech Hunter | Biotech Hunter